- Home
- HPK vs RXST Comparison
HPK vs RXST Comparison
Compare HPK & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPK
- RXST
- Stock Information
- Founded
- HPK 2019
- RXST 1997
- Country
- HPK United States
- RXST United States
- Employees
- HPK 47
- RXST N/A
- Industry
- HPK Oil & Gas Production
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HPK Energy
- RXST Health Care
- Exchange
- HPK Nasdaq
- RXST Nasdaq
- Market Cap
- HPK 1.1B
- RXST 1.0B
- IPO Year
- HPK N/A
- RXST 2021
- Fundamental
- Price
- HPK $9.14
- RXST $13.06
- Analyst Decision
- HPK Sell
- RXST Buy
- Analyst Count
- HPK 2
- RXST 10
- Target Price
- HPK $11.50
- RXST $38.50
- AVG Volume (30 Days)
- HPK 329.3K
- RXST 1.1M
- Earning Date
- HPK 05-12-2025
- RXST 05-07-2025
- Dividend Yield
- HPK 1.76%
- RXST N/A
- EPS Growth
- HPK N/A
- RXST N/A
- EPS
- HPK 0.67
- RXST N/A
- Revenue
- HPK $1,069,414,000.00
- RXST $148,310,000.00
- Revenue This Year
- HPK N/A
- RXST $24.14
- Revenue Next Year
- HPK N/A
- RXST $21.47
- P/E Ratio
- HPK $13.66
- RXST N/A
- Revenue Growth
- HPK N/A
- RXST 46.70
- 52 Week Low
- HPK $7.82
- RXST $13.50
- 52 Week High
- HPK $17.48
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- HPK 48.13
- RXST 32.41
- Support Level
- HPK $7.87
- RXST $13.72
- Resistance Level
- HPK $8.25
- RXST $15.41
- Average True Range (ATR)
- HPK 0.49
- RXST 0.90
- MACD
- HPK 0.13
- RXST 0.28
- Stochastic Oscillator
- HPK 63.13
- RXST 1.00
About HPK HighPeak Energy Inc.
HighPeak Energy Inc is an independent crude oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.